In the last 12 months, insiders at COLLEGIUM PHARMACEUTICAL, INC ($COLL) filed 205 transactions with the SEC: 0 open-market purchases totaling $0 and 68 sales totaling $32,496,109. Net insider sentiment: net selling.
COLLEGIUM PHARMACEUTICAL, INC operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Dreyer Scott (EVP & Chief Commercial Officer) — 48 transactions totaling $17,582,693
- Ciaffoni Joseph (President and CEO) — 28 transactions totaling $14,105,103
- Kuhlmann Shirley R. (EVP and General Counsel) — 32 transactions totaling $11,296,095
- Tupper Colleen (EVP & Chief Financial Officer) — 26 transactions totaling $7,224,562
- Smith Thomas B (EVP and Chief Medical Officer) — 16 transactions totaling $2,162,345
View all SEC Filings for COLLEGIUM PHARMACEUTICAL, INC (COLL).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | Dieter David | EVP & General Counsel | F | Common Stock | 8840 | $35.72 | 68,231.0000 | 40,076,457 | 11.47% | 0.02% |
| March 18, 2026 | Dieter David | EVP & General Counsel | S | Common Stock | 13976 | $34.92 | 77,071.0000 | 40,076,457 | 15.35% | 0.03% |
| March 9, 2026 | Dieter David | EVP & General Counsel | S | Common Stock | 6224 | $36.65 | 91,047.0000 | 40,076,457 | 6.40% | 0.02% |
| March 3, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 46417 | $40.36 | 75,329.0000 | 40,076,457 | 38.13% | 0.12% |
| March 3, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 3559 | $40.99 | 71,770.0000 | 40,076,457 | 4.72% | 0.01% |
| Feb. 10, 2026 | Dieter David | EVP & General Counsel | A | Common Stock | 22194 | $0.00 | 91,047.0000 | 40,076,457 | 32.23% | 0.06% |
| Feb. 10, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | F | Common Stock | 21615 | $46.75 | 121,746.0000 | 40,076,457 | 15.08% | 0.05% |
| Feb. 10, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | F | Common Stock | 9977 | $46.75 | 143,361.0000 | 40,076,457 | 6.51% | 0.02% |
| Feb. 10, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | A | Common Stock | 30702 | $0.00 | 153,338.0000 | 40,076,457 | 25.04% | 0.08% |
| Feb. 10, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | A | Common Stock | 19023 | $0.00 | 122,636.0000 | 40,076,457 | 18.36% | 0.05% |
| Feb. 10, 2026 | Tupper Colleen | EVP & Chief Financial Officer | F | Common Stock | 26679 | $46.75 | 147,282.0000 | 40,076,457 | 15.34% | 0.07% |
| Feb. 10, 2026 | Tupper Colleen | EVP & Chief Financial Officer | F | Common Stock | 11861 | $46.75 | 173,961.0000 | 40,076,457 | 6.38% | 0.03% |
| Feb. 10, 2026 | Tupper Colleen | EVP & Chief Financial Officer | A | Common Stock | 32734 | $0.00 | 185,822.0000 | 40,076,457 | 21.38% | 0.08% |
| Feb. 10, 2026 | Tupper Colleen | EVP & Chief Financial Officer | A | Common Stock | 26421 | $0.00 | 153,088.0000 | 40,076,457 | 20.86% | 0.07% |
| Feb. 10, 2026 | Smith Thomas B | EVP and Chief Medical Officer | F | Common Stock | 11538 | $46.75 | 90,651.0000 | 40,076,457 | 11.29% | 0.03% |
| Feb. 10, 2026 | Smith Thomas B | EVP and Chief Medical Officer | F | Common Stock | 5897 | $46.75 | 102,189.0000 | 40,076,457 | 5.46% | 0.01% |
| Feb. 10, 2026 | Smith Thomas B | EVP and Chief Medical Officer | A | Common Stock | 22774 | $0.00 | 108,086.0000 | 40,076,457 | 26.69% | 0.06% |
| Feb. 10, 2026 | Smith Thomas B | EVP and Chief Medical Officer | A | Common Stock | 14268 | $0.00 | 85,312.0000 | 40,076,457 | 20.08% | 0.04% |
| Feb. 10, 2026 | Karnani Vikram | President and CEO | F | Common Stock | 11296 | $46.75 | 197,864.0000 | 40,076,457 | 5.40% | 0.03% |
| Feb. 10, 2026 | Karnani Vikram | President and CEO | A | Common Stock | 32531 | $0.00 | 209,160.0000 | 40,076,457 | 18.42% | 0.08% |
| Feb. 10, 2026 | Karnani Vikram | President and CEO | A | Common Stock | 79264 | $0.00 | 176,629.0000 | 40,076,457 | 81.41% | 0.20% |
| Feb. 10, 2026 | Dieter David | EVP & General Counsel | F | Common Stock | 2781 | $46.75 | 97,271.0000 | 40,076,457 | 2.78% | 0.01% |
| Feb. 10, 2026 | Dieter David | EVP & General Counsel | A | Common Stock | 9005 | $0.00 | 100,052.0000 | 40,076,457 | 9.89% | 0.02% |
| Dec. 8, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | M | Stock Option (Right to Purchase) | 17600 | $0.00 | 0.0000 | 39,439,890 | 100.00% | 0.04% |
| Dec. 8, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | M | Common Stock | 17600 | $15.90 | 121,213.0000 | 39,439,890 | 16.99% | 0.04% |
| Dec. 8, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 11125 | $47.89 | 110,088.0000 | 39,439,890 | 9.18% | 0.03% |
| Dec. 8, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 6475 | $48.66 | 103,613.0000 | 39,439,890 | 5.88% | 0.02% |
| Dec. 5, 2025 | Balice-Gordon Rita J. | Not found | S | Common Stock | 3650 | $47.03 | 52,629.0000 | 39,439,890 | 6.49% | 0.01% |
| Nov. 12, 2025 | Fallon John A. | Not found | M | Common Stock | 15000 | $16.49 | 79,634.0000 | 39,439,890 | 23.21% | 0.04% |
| Nov. 12, 2025 | Fallon John A. | Not found | M | Stock Option (Right to Purchase) | 19853 | $0.00 | 0.0000 | 39,439,890 | 100.00% | 0.05% |
| Nov. 12, 2025 | Fallon John A. | Not found | M | Stock Option (Right to Purchase) | 15000 | $0.00 | 0.0000 | 39,439,890 | 100.00% | 0.04% |
| Nov. 12, 2025 | Fallon John A. | Not found | S | Common Stock | 34853 | $47.21 | 64,634.0000 | 39,439,890 | 35.03% | 0.09% |
| Nov. 12, 2025 | Fallon John A. | Not found | M | Common Stock | 19853 | $9.33 | 99,487.0000 | 39,439,890 | 24.93% | 0.05% |
| Nov. 12, 2025 | Karnani Vikram | President and CEO | F | Common Stock | 8983 | $47.35 | 96,989.0000 | 39,439,890 | 8.48% | 0.02% |
| Nov. 6, 2025 | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 4858 | $41.28 | 126,667.0000 | 39,439,890 | 3.69% | 0.01% |
| Nov. 6, 2025 | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 25142 | $40.38 | 131,525.0000 | 39,439,890 | 16.05% | 0.06% |
| Aug. 29, 2025 | Smith Thomas B | EVP and Chief Medical Officer | S | Common Stock | 17478 | $38.42 | 70,264.0000 | 39,075,703 | 19.92% | 0.04% |
| Aug. 18, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 16389 | $38.21 | 103,613.0000 | 39,075,703 | 13.66% | 0.04% |
| Aug. 18, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | M | Common Stock | 16389 | $21.34 | 120,002.0000 | 39,075,703 | 15.82% | 0.04% |
| Aug. 18, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | M | Stock Option (Right to Purchase) | 16389 | $0.00 | 0.0000 | 39,075,703 | 100.00% | 0.04% |
| Aug. 15, 2025 | SANTINI GINO | Director | M | Common Stock | 15000 | $13.45 | 100,447.0000 | 39,075,703 | 17.55% | 0.04% |
| Aug. 15, 2025 | SANTINI GINO | Director | M | Stock Option (Right to Purchase) | 15000 | $0.00 | 0.0000 | 39,075,703 | 100.00% | 0.04% |
| Aug. 15, 2025 | SANTINI GINO | Director | S | Common Stock | 5405 | $37.19 | 95,042.0000 | 39,075,703 | 5.38% | 0.01% |
| Aug. 13, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | M | Stock Option (Right to Purchase) | 4861 | $0.00 | 16,389.0000 | 39,075,703 | 22.88% | 0.01% |
| Aug. 13, 2025 | Rubric Capital Management LP | TenPercentOwner | S | Common Stock, par value $0.001 per share | 25000 | $37.85 | 3,132,743.0000 | 39,075,703 | 0.79% | 0.06% |
| Aug. 13, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | M | Common Stock | 4861 | $21.34 | 108,474.0000 | 39,075,703 | 4.69% | 0.01% |
| Aug. 13, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 4861 | $38.03 | 103,613.0000 | 39,075,703 | 4.48% | 0.01% |
| Aug. 8, 2025 | Freund John Gordon | Director | S | Common Stock | 11659 | $34.36 | 102,412.0000 | 39,075,703 | 10.22% | 0.03% |
| June 9, 2025 | Freund John Gordon | Director | M | Common Stock | 15000 | $13.45 | 120,672.0000 | 32,840,153 | 14.19% | 0.05% |
| June 9, 2025 | Freund John Gordon | Director | M | Stock Option (Right to Purchase) | 15000 | $0.00 | 0.0000 | 32,840,153 | 100.00% | 0.05% |
| June 9, 2025 | Freund John Gordon | Director | S | Common Stock | 6601 | $30.62 | 114,071.0000 | 32,840,153 | 5.47% | 0.02% |
| May 15, 2025 | Freund John Gordon | Director | A | Common Stock | 9791 | $0.00 | 105,672.0000 | 32,840,153 | 10.21% | 0.03% |
| May 15, 2025 | Paya Carlos V | Director | A | Common Stock | 19582 | $0.00 | 19,582.0000 | 32,840,153 | 9999.99% | 0.06% |
| May 15, 2025 | Fallon John A. | Director | A | Common Stock | 9791 | $0.00 | 64,634.0000 | 32,840,153 | 17.85% | 0.03% |
| May 15, 2025 | Lurker Nancy | Director | A | Common Stock | 9791 | $0.00 | 22,517.0000 | 32,840,153 | 76.94% | 0.03% |
| May 15, 2025 | BOHLIN GAREN G | Director | A | Common Stock | 9791 | $0.00 | 62,259.0000 | 32,840,153 | 18.66% | 0.03% |
| May 15, 2025 | Balice-Gordon Rita J. | Director | A | Common Stock | 9791 | $0.00 | 56,279.0000 | 32,840,153 | 21.06% | 0.03% |
| May 15, 2025 | SANTINI GINO | Director | A | Common Stock | 9791 | $0.00 | 85,447.0000 | 32,840,153 | 12.94% | 0.03% |
| March 21, 2025 | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 6396 | $30.03 | 156,667.0000 | 40,109,649 | 3.92% | 0.02% |
| March 21, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 18881 | $30.03 | 103,613.0000 | 40,109,649 | 15.41% | 0.05% |
| March 20, 2025 | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 1206 | $30.00 | 163,063.0000 | 40,109,649 | 0.73% | 0.00% |
| March 20, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 1927 | $30.00 | 122,494.0000 | 40,109,649 | 1.55% | 0.00% |
| March 17, 2025 | Dieter David | EVP & General Counsel | A | Common Stock | 68449 | $0.00 | 68,449.0000 | 40,109,649 | 9999.99% | 0.17% |
| March 14, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 2255 | $30.00 | 124,421.0000 | 40,109,649 | 1.78% | 0.01% |
| March 14, 2025 | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 977 | $30.00 | 164,269.0000 | 40,109,649 | 0.59% | 0.00% |
| March 11, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 15387 | $30.00 | 126,676.0000 | 40,109,649 | 10.83% | 0.04% |
| March 6, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 15387 | $30.00 | 126,676.0000 | 40,109,649 | 10.83% | 0.04% |
| March 11, 2025 | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 10445 | $30.01 | 165,246.0000 | 40,109,649 | 5.95% | 0.03% |
| March 7, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 2348 | $30.00 | 142,063.0000 | 40,109,649 | 1.63% | 0.01% |
| March 6, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 3295 | $30.00 | 144,411.0000 | 40,109,649 | 2.23% | 0.01% |
| March 7, 2025 | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 1504 | $30.00 | 175,691.0000 | 40,109,649 | 0.85% | 0.00% |
| March 6, 2025 | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 1949 | $30.00 | 177,195.0000 | 40,109,649 | 1.09% | 0.00% |
| March 6, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | S | Common Stock | 26067 | $28.50 | 108,137.0000 | 40,109,649 | 19.42% | 0.06% |
| March 4, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | M | Stock Option (Right to Purchase) | 40000 | $0.00 | 0.0000 | 40,109,649 | 100.00% | 0.10% |
| March 5, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | S | Common Stock | 20000 | $28.03 | 134,204.0000 | 40,109,649 | 12.97% | 0.05% |
| March 4, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | S | Common Stock | 40000 | $28.08 | 154,204.0000 | 40,109,649 | 20.60% | 0.10% |
| March 4, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | M | Common Stock | 40000 | $24.03 | 194,204.0000 | 40,109,649 | 25.94% | 0.10% |
| Feb. 10, 2025 | Smith Thomas B | EVP and Chief Medical Officer | A | Common Stock | 33762 | $0.00 | 88,326.0000 | 40,109,649 | 61.88% | 0.08% |
| Feb. 10, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | F | Common Stock | 25149 | $30.52 | 154,204.0000 | 40,109,649 | 14.02% | 0.06% |
| Feb. 10, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | F | Common Stock | 9826 | $30.52 | 179,353.0000 | 40,109,649 | 5.19% | 0.02% |
| Feb. 10, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | A | Common Stock | 29030 | $0.00 | 189,179.0000 | 40,109,649 | 18.13% | 0.07% |
| Feb. 10, 2025 | Tupper Colleen | EVP & Chief Financial Officer | A | Common Stock | 26957 | $0.00 | 209,570.0000 | 40,109,649 | 14.76% | 0.07% |
| Feb. 10, 2025 | Tupper Colleen | EVP & Chief Financial Officer | F | Common Stock | 8109 | $30.52 | 201,461.0000 | 40,109,649 | 3.87% | 0.02% |
| Feb. 10, 2025 | Tupper Colleen | EVP & Chief Financial Officer | F | Common Stock | 22317 | $30.52 | 179,144.0000 | 40,109,649 | 11.08% | 0.06% |
| Feb. 10, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | A | Common Stock | 40965 | $0.00 | 160,149.0000 | 40,109,649 | 34.37% | 0.10% |
| Feb. 10, 2025 | Heffernan Michael Thomas | Director | A | Common Stock | 4820 | $0.00 | 50,328.0000 | 40,109,649 | 10.59% | 0.01% |
| Feb. 10, 2025 | Smith Thomas B | EVP and Chief Medical Officer | A | Common Stock | 5313 | $0.00 | 93,639.0000 | 40,109,649 | 6.02% | 0.01% |
| Feb. 10, 2025 | Smith Thomas B | EVP and Chief Medical Officer | F | Common Stock | 1498 | $30.52 | 92,141.0000 | 40,109,649 | 1.60% | 0.00% |
| Feb. 10, 2025 | Smith Thomas B | EVP and Chief Medical Officer | F | Common Stock | 4399 | $30.52 | 87,742.0000 | 40,109,649 | 4.77% | 0.01% |
| Feb. 10, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | A | Common Stock | 45016 | $0.00 | 150,918.0000 | 40,109,649 | 42.51% | 0.11% |
| Feb. 10, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | A | Common Stock | 26411 | $0.00 | 177,329.0000 | 40,109,649 | 17.50% | 0.07% |
| Feb. 10, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | F | Common Stock | 7953 | $30.52 | 169,376.0000 | 40,109,649 | 4.48% | 0.02% |
| Feb. 10, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | F | Common Stock | 21670 | $30.52 | 147,706.0000 | 40,109,649 | 12.79% | 0.05% |
| Feb. 10, 2025 | Tupper Colleen | EVP & Chief Financial Officer | A | Common Stock | 51768 | $0.00 | 182,613.0000 | 40,109,649 | 39.56% | 0.13% |
| Feb. 4, 2025 | Lurker Nancy | Director | A | Common Stock | 12726 | $0.00 | 12,726.0000 | 40,109,649 | 9999.99% | 0.03% |
| Jan. 10, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | S | Common Stock | 6100 | $33.64 | 119,184.0000 | 40,109,649 | 4.87% | 0.02% |
| Jan. 10, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | M | Common Stock | 27500 | $21.34 | 146,684.0000 | 40,109,649 | 23.07% | 0.07% |
| Jan. 10, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | S | Common Stock | 21400 | $32.87 | 125,284.0000 | 40,109,649 | 14.59% | 0.05% |
| Jan. 10, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | M | Stock Option (Right to Purchase) | 27500 | $0.00 | 0.0000 | 40,109,649 | 100.00% | 0.07% |
| Nov. 12, 2024 | Karnani Vikram | President and CEO | A | Common Stock | 105972 | $0.00 | 105,972.0000 | 40,163,266 | 9999.99% | 0.26% |
| Nov. 12, 2024 | Karnani Vikram | President and CEO | A | Stock Option (Right to Purchase) | 130344 | $0.00 | 130,344.0000 | 40,163,266 | 9999.99% | 0.32% |
| Sept. 13, 2024 | Smith Thomas B | EVP and Chief Medical Officer | S | Common Stock | 9593 | $36.62 | 53,816.0000 | 40,383,694 | 15.13% | 0.02% |
| Sept. 6, 2024 | Kuhlmann Shirley R. | EVP and General Counsel | S | Common Stock | 977 | $37.46 | 119,184.0000 | 40,383,694 | 0.81% | 0.00% |
| Sept. 5, 2024 | Kuhlmann Shirley R. | EVP and General Counsel | S | Common Stock | 16848 | $38.18 | 122,561.0000 | 40,383,694 | 12.09% | 0.04% |
| Sept. 5, 2024 | Kuhlmann Shirley R. | EVP and General Counsel | S | Common Stock | 2400 | $39.14 | 120,161.0000 | 40,383,694 | 1.96% | 0.01% |
| June 3, 2024 | Kuhlmann Shirley R. | EVP and General Counsel | S | Common Stock | 24300 | $32.55 | 140,109.0000 | 41,438,466 | 14.78% | 0.06% |
| June 3, 2024 | Kuhlmann Shirley R. | EVP and General Counsel | S | Common Stock | 700 | $33.22 | 139,409.0000 | 41,438,466 | 0.50% | 0.00% |
| May 28, 2024 | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 19710 | $34.21 | 130,845.0000 | 41,438,466 | 13.09% | 0.05% |
| May 23, 2024 | Dreyer Scott | EVP & Chief Commercial Officer | M | Common Stock | 51209 | $24.03 | 190,127.0000 | 41,438,466 | 36.86% | 0.12% |
| May 24, 2024 | Dreyer Scott | EVP & Chief Commercial Officer | M | Stock Option (Right to Purchase) | 23791 | $0.00 | 0.0000 | 41,438,466 | 100.00% | 0.06% |
| May 24, 2024 | Dreyer Scott | EVP & Chief Commercial Officer | M | Common Stock | 23791 | $24.03 | 162,709.0000 | 41,438,466 | 17.13% | 0.06% |
| May 23, 2024 | Dreyer Scott | EVP & Chief Commercial Officer | M | Stock Option (Right to Purchase) | 51209 | $0.00 | 23,791.0000 | 41,438,466 | 68.28% | 0.12% |
| May 24, 2024 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 56807 | $33.98 | 105,902.0000 | 41,438,466 | 34.91% | 0.14% |
| May 23, 2024 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 51209 | $33.82 | 138,918.0000 | 41,438,466 | 26.93% | 0.12% |
| May 16, 2024 | Fallon John A. | Director | A | Common Stock | 7693 | $0.00 | 54,843.0000 | 41,438,466 | 16.32% | 0.02% |
| May 16, 2024 | SANTINI GINO | Director | A | Common Stock | 7693 | $0.00 | 75,656.0000 | 41,438,466 | 11.32% | 0.02% |
| May 16, 2024 | Melincoff Gwen A | Director | A | Common Stock | 7693 | $0.00 | 52,468.0000 | 41,438,466 | 17.18% | 0.02% |
| May 16, 2024 | McFarlane Neil F. | Director | A | Common Stock | 7693 | $0.00 | 49,365.0000 | 41,438,466 | 18.46% | 0.02% |
| May 16, 2024 | Freund John Gordon | Director | A | Common Stock | 7693 | $0.00 | 95,881.0000 | 41,438,466 | 8.72% | 0.02% |
| May 16, 2024 | Balice-Gordon Rita J. | Director | A | Common Stock | 7693 | $0.00 | 46,488.0000 | 41,438,466 | 19.83% | 0.02% |
| May 16, 2024 | Heffernan Michael Thomas | Director | A | Common Stock | 7693 | $0.00 | 45,508.0000 | 41,438,466 | 20.34% | 0.02% |
| May 14, 2024 | BOHLIN GAREN G | Director | M | Common Stock | 28985 | $5.73 | 73,760.0000 | 41,438,466 | 64.73% | 0.07% |
| May 14, 2024 | BOHLIN GAREN G | Director | S | Common Stock | 28985 | $32.30 | 44,775.0000 | 41,438,466 | 39.30% | 0.07% |
| May 16, 2024 | BOHLIN GAREN G | Director | A | Common Stock | 7693 | $0.00 | 52,468.0000 | 41,438,466 | 17.18% | 0.02% |
| May 14, 2024 | BOHLIN GAREN G | Director | M | Stock Option (Right to Purchase) | 28985 | $0.00 | 0.0000 | 41,438,466 | 100.00% | 0.07% |
| Feb. 29, 2024 | Smith Thomas B | EVP and Chief Medical Officer | S | Common Stock | 995 | $36.76 | 63,409.0000 | 41,279,981 | 1.54% | 0.00% |
| Feb. 26, 2024 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 664 | $37.15 | 138,918.0000 | 41,279,981 | 0.48% | 0.00% |
| Feb. 26, 2024 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 9336 | $36.38 | 139,582.0000 | 41,279,981 | 6.27% | 0.02% |
| Feb. 12, 2024 | Ciaffoni Joseph | President and CEO | F | Common Stock | 47445 | $33.70 | 526,289.0000 | 41,279,981 | 8.27% | 0.11% |
| Feb. 12, 2024 | Ciaffoni Joseph | President and CEO | A | Common Stock | 179734 | $0.00 | 573,734.0000 | 41,279,981 | 45.62% | 0.44% |
| Feb. 12, 2024 | Ciaffoni Joseph | President and CEO | A | Common Stock | 119000 | $0.00 | 394,000.0000 | 41,279,981 | 43.27% | 0.29% |
| Feb. 12, 2024 | Kuhlmann Shirley R. | EVP and General Counsel | F | Common Stock | 10610 | $33.70 | 164,409.0000 | 41,279,981 | 6.06% | 0.03% |
| Feb. 12, 2024 | Kuhlmann Shirley R. | EVP and General Counsel | F | Common Stock | 21146 | $33.70 | 175,019.0000 | 41,279,981 | 10.78% | 0.05% |
| Feb. 12, 2024 | Kuhlmann Shirley R. | EVP and General Counsel | A | Common Stock | 33247 | $0.00 | 196,165.0000 | 41,279,981 | 20.41% | 0.08% |
| Feb. 12, 2024 | Kuhlmann Shirley R. | EVP and General Counsel | A | Common Stock | 43400 | $0.00 | 162,918.0000 | 41,279,981 | 36.31% | 0.11% |
| Feb. 12, 2024 | Smith Thomas B | EVP and Chief Medical Officer | A | Common Stock | 4623 | $0.00 | 67,603.0000 | 41,279,981 | 7.34% | 0.01% |
| Feb. 12, 2024 | Smith Thomas B | EVP and Chief Medical Officer | F | Common Stock | 1300 | $33.70 | 64,404.0000 | 41,279,981 | 1.98% | 0.00% |
| Feb. 12, 2024 | Ciaffoni Joseph | President and CEO | F | Common Stock | 81422 | $33.70 | 444,867.0000 | 41,279,981 | 15.47% | 0.20% |
| Feb. 12, 2024 | Smith Thomas B | EVP and Chief Medical Officer | F | Common Stock | 1899 | $33.70 | 65,704.0000 | 41,279,981 | 2.81% | 0.00% |
| Feb. 12, 2024 | Tupper Colleen | EVP & Chief Financial Officer | A | Common Stock | 40600 | $0.00 | 146,020.0000 | 41,279,981 | 38.51% | 0.10% |
| Feb. 12, 2024 | Tupper Colleen | EVP & Chief Financial Officer | A | Common Stock | 30856 | $0.00 | 176,876.0000 | 41,279,981 | 21.13% | 0.07% |
| Feb. 12, 2024 | Tupper Colleen | EVP & Chief Financial Officer | F | Common Stock | 16868 | $33.70 | 160,008.0000 | 41,279,981 | 9.54% | 0.04% |
| Feb. 12, 2024 | Tupper Colleen | EVP & Chief Financial Officer | F | Common Stock | 9453 | $33.70 | 150,555.0000 | 41,279,981 | 5.91% | 0.02% |
| Feb. 12, 2024 | Dreyer Scott | EVP & Chief Commercial Officer | A | Common Stock | 35000 | $0.00 | 146,322.0000 | 41,279,981 | 31.44% | 0.08% |
| Feb. 12, 2024 | Dreyer Scott | EVP & Chief Commercial Officer | A | Common Stock | 32286 | $0.00 | 178,608.0000 | 41,279,981 | 22.07% | 0.08% |
| Feb. 12, 2024 | Dreyer Scott | EVP & Chief Commercial Officer | F | Common Stock | 19545 | $33.70 | 159,063.0000 | 41,279,981 | 10.94% | 0.05% |
| Feb. 12, 2024 | Dreyer Scott | EVP & Chief Commercial Officer | F | Common Stock | 10145 | $33.70 | 148,918.0000 | 41,279,981 | 6.38% | 0.02% |
| Feb. 12, 2024 | Smith Thomas B | EVP and Chief Medical Officer | A | Common Stock | 30800 | $0.00 | 62,980.0000 | 41,279,981 | 95.71% | 0.07% |
| Jan. 16, 2024 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 23560 | $32.28 | 111,322.0000 | 41,279,981 | 17.47% | 0.06% |
| Dec. 21, 2023 | Ciaffoni Joseph | President and CEO | M | Common Stock | 4357 | $21.34 | 279,357.0000 | 42,058,821 | 1.58% | 0.01% |
| Dec. 21, 2023 | Ciaffoni Joseph | President and CEO | M | Stock Option (Right to Purchase) | 4357 | $0.00 | 16,875.0000 | 42,058,821 | 20.52% | 0.01% |
| Dec. 21, 2023 | Ciaffoni Joseph | President and CEO | S | Common Stock | 4357 | $30.38 | 275,000.0000 | 42,058,821 | 1.56% | 0.01% |
| Dec. 19, 2023 | Ciaffoni Joseph | President and CEO | S | Common Stock | 14516 | $30.03 | 275,000.0000 | 42,058,821 | 5.01% | 0.03% |
| Dec. 19, 2023 | Ciaffoni Joseph | President and CEO | M | Common Stock | 14516 | $21.34 | 289,516.0000 | 42,058,821 | 5.28% | 0.03% |
| Dec. 20, 2023 | Ciaffoni Joseph | President and CEO | M | Stock Option (Right to Purchase) | 26454 | $0.00 | 21,232.0000 | 42,058,821 | 55.48% | 0.06% |
| Dec. 19, 2023 | Ciaffoni Joseph | President and CEO | M | Stock Option (Right to Purchase) | 14516 | $0.00 | 47,686.0000 | 42,058,821 | 23.34% | 0.03% |
| Dec. 18, 2023 | Ciaffoni Joseph | President and CEO | M | Stock Option (Right to Purchase) | 27798 | $0.00 | 62,202.0000 | 42,058,821 | 30.89% | 0.07% |
| Dec. 20, 2023 | Ciaffoni Joseph | President and CEO | S | Common Stock | 26454 | $30.40 | 275,000.0000 | 42,058,821 | 8.78% | 0.06% |
| Dec. 20, 2023 | Ciaffoni Joseph | President and CEO | M | Common Stock | 26454 | $21.34 | 301,454.0000 | 42,058,821 | 9.62% | 0.06% |
| Dec. 18, 2023 | Ciaffoni Joseph | President and CEO | M | Common Stock | 27798 | $21.34 | 302,798.0000 | 42,058,821 | 10.11% | 0.07% |
| Dec. 18, 2023 | Ciaffoni Joseph | President and CEO | S | Common Stock | 27798 | $30.04 | 275,000.0000 | 42,058,821 | 9.18% | 0.07% |
| Nov. 27, 2023 | Kuhlmann Shirley R. | EVP and General Counsel | M | Stock Option (Right to Purchase) | 25600 | $0.00 | 0.0000 | 42,058,821 | 100.00% | 0.06% |
| Nov. 27, 2023 | Kuhlmann Shirley R. | EVP and General Counsel | M | Common Stock | 25600 | $15.90 | 145,118.0000 | 42,058,821 | 21.42% | 0.06% |
| Nov. 27, 2023 | Kuhlmann Shirley R. | EVP and General Counsel | S | Common Stock | 25600 | $25.78 | 119,518.0000 | 42,058,821 | 17.64% | 0.06% |
| June 26, 2023 | Kuhlmann Shirley R. | EVP and General Counsel | S | Common Stock | 1363 | $22.53 | 119,518.0000 | 34,319,291 | 1.13% | 0.00% |
| June 26, 2023 | Kuhlmann Shirley R. | EVP and General Counsel | S | Common Stock | 16621 | $21.65 | 120,881.0000 | 34,319,291 | 12.09% | 0.05% |
| June 1, 2023 | Ciaffoni Joseph | President and CEO | S | Common Stock | 31272 | $22.09 | 306,272.0000 | 34,319,291 | 9.26% | 0.09% |
| June 2, 2023 | Ciaffoni Joseph | President and CEO | S | Common Stock | 1000 | $22.25 | 275,000.0000 | 34,319,291 | 0.36% | 0.00% |
| June 2, 2023 | Ciaffoni Joseph | President and CEO | S | Common Stock | 30272 | $21.58 | 276,000.0000 | 34,319,291 | 9.88% | 0.09% |
| May 31, 2023 | Ciaffoni Joseph | President and CEO | S | Common Stock | 31272 | $21.87 | 337,544.0000 | 34,319,291 | 8.48% | 0.09% |
| May 30, 2023 | Ciaffoni Joseph | President and CEO | S | Common Stock | 31271 | $21.90 | 368,816.0000 | 34,319,291 | 7.82% | 0.09% |
| May 18, 2023 | Melincoff Gwen A | Director | A | Common Stock | 9792 | $0.00 | 44,775.0000 | 34,319,291 | 27.99% | 0.03% |
| May 18, 2023 | Fallon John A. | Director | A | Common Stock | 9792 | $0.00 | 47,150.0000 | 34,319,291 | 26.21% | 0.03% |
| May 18, 2023 | Freund John Gordon | Director | A | Common Stock | 9792 | $0.00 | 88,188.0000 | 34,319,291 | 12.49% | 0.03% |
| May 18, 2023 | Heffernan Michael Thomas | Director | A | Common Stock | 9792 | $0.00 | 37,815.0000 | 34,319,291 | 34.94% | 0.03% |
| May 18, 2023 | McFarlane Neil F. | Director | A | Common Stock | 9792 | $0.00 | 41,672.0000 | 34,319,291 | 30.72% | 0.03% |
| May 18, 2023 | Balice-Gordon Rita J. | Director | A | Common Stock | 9792 | $0.00 | 38,795.0000 | 34,319,291 | 33.76% | 0.03% |
| May 18, 2023 | BOHLIN GAREN G | Director | A | Common Stock | 9792 | $0.00 | 44,775.0000 | 34,319,291 | 27.99% | 0.03% |
| May 18, 2023 | SANTINI GINO | Director | A | Common Stock | 9792 | $0.00 | 67,963.0000 | 34,319,291 | 16.83% | 0.03% |
| March 15, 2023 | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 31640 | $23.77 | 105,420.0000 | 33,582,202 | 23.08% | 0.09% |
| March 1, 2023 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 13324 | $26.70 | 134,882.0000 | 33,582,202 | 8.99% | 0.04% |
| Feb. 10, 2023 | Ciaffoni Joseph | President and CEO | A | Common Stock | 137694 | $0.00 | 503,944.0000 | 33,582,202 | 37.60% | 0.41% |
| Feb. 10, 2023 | Kuhlmann Shirley R. | EVP and General Counsel | A | Common Stock | 25739 | $0.00 | 183,359.0000 | 33,582,202 | 16.33% | 0.08% |
| Feb. 10, 2023 | Kuhlmann Shirley R. | EVP and General Counsel | A | Common Stock | 48125 | $0.00 | 157,620.0000 | 33,582,202 | 43.95% | 0.14% |
| Feb. 10, 2023 | Smith Thomas B | EVP and Chief Medical Officer | A | Common Stock | 31185 | $0.00 | 31,185.0000 | 33,582,202 | 9999.99% | 0.09% |
| Feb. 10, 2023 | Kuhlmann Shirley R. | EVP and General Counsel | F | Common Stock | 16291 | $26.75 | 167,068.0000 | 33,582,202 | 8.88% | 0.05% |
| Feb. 10, 2023 | Ciaffoni Joseph | President and CEO | F | Common Stock | 44121 | $26.75 | 459,823.0000 | 33,582,202 | 8.76% | 0.13% |
| Feb. 10, 2023 | Ciaffoni Joseph | President and CEO | F | Common Stock | 59736 | $26.75 | 400,087.0000 | 33,582,202 | 12.99% | 0.18% |
| Feb. 13, 2023 | Ciaffoni Joseph | President and CEO | M | Common Stock | 11250 | $15.90 | 411,337.0000 | 33,582,202 | 2.81% | 0.03% |
| Feb. 13, 2023 | Ciaffoni Joseph | President and CEO | S | Common Stock | 11250 | $26.88 | 400,087.0000 | 33,582,202 | 2.73% | 0.03% |
| Feb. 13, 2023 | Ciaffoni Joseph | President and CEO | M | Stock Option (Right to Purchase) | 11250 | $0.00 | 0.0000 | 33,582,202 | 100.00% | 0.03% |
| Feb. 10, 2023 | Dreyer Scott | EVP & Chief Commercial Officer | A | Common Stock | 44275 | $0.00 | 147,073.0000 | 33,582,202 | 43.07% | 0.13% |
| Feb. 10, 2023 | Dreyer Scott | EVP & Chief Commercial Officer | A | Common Stock | 22459 | $0.00 | 169,532.0000 | 33,582,202 | 15.27% | 0.07% |
| Feb. 10, 2023 | Dreyer Scott | EVP & Chief Commercial Officer | F | Common Stock | 14529 | $26.75 | 155,003.0000 | 33,582,202 | 8.57% | 0.04% |
| Feb. 10, 2023 | Dreyer Scott | EVP & Chief Commercial Officer | F | Common Stock | 6797 | $26.75 | 148,206.0000 | 33,582,202 | 4.39% | 0.02% |
| Feb. 10, 2023 | Ciaffoni Joseph | President and CEO | A | Common Stock | 117500 | $0.00 | 366,250.0000 | 33,582,202 | 47.24% | 0.35% |
| Feb. 10, 2023 | Tupper Colleen | EVP & Chief Financial Officer | F | Common Stock | 3887 | $26.75 | 137,060.0000 | 33,582,202 | 2.76% | 0.01% |
| Feb. 10, 2023 | Tupper Colleen | EVP & Chief Financial Officer | F | Common Stock | 6967 | $26.75 | 140,947.0000 | 33,582,202 | 4.71% | 0.02% |
| Feb. 10, 2023 | Tupper Colleen | EVP & Chief Financial Officer | A | Common Stock | 12565 | $0.00 | 147,914.0000 | 33,582,202 | 9.28% | 0.04% |
| Feb. 10, 2023 | Tupper Colleen | EVP & Chief Financial Officer | A | Common Stock | 45045 | $0.00 | 135,349.0000 | 33,582,202 | 49.88% | 0.13% |
| Feb. 13, 2023 | Kuhlmann Shirley R. | EVP and General Counsel | S | Common Stock | 21811 | $26.88 | 137,502.0000 | 33,582,202 | 13.69% | 0.06% |
| Feb. 10, 2023 | Kuhlmann Shirley R. | EVP and General Counsel | F | Common Stock | 7755 | $26.75 | 159,313.0000 | 33,582,202 | 4.64% | 0.02% |
| Jan. 9, 2023 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 69 | $28.58 | 102,798.0000 | 33,582,202 | 0.07% | 0.00% |
| Jan. 9, 2023 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 7341 | $27.83 | 102,867.0000 | 33,582,202 | 6.66% | 0.02% |
| Jan. 9, 2023 | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 10424 | $27.08 | 110,208.0000 | 33,582,202 | 8.64% | 0.03% |